1 Basurto D, Russo FM, Van der Veeken L, Van der Merwe J, Stuart Hooper S, Benachi A, et al. Prenatal diagnosis and management of congenital diaphragmatic hernia. Best Practice & Research Clinical Obstetrics and Gynaecology. 2019;58:93–106.
2 Snoeka KG, Reissa, Greenoughc A, Capolupoe I, Urlesbergerf B, Wessel L, et al. Standardized Postnatal Management of Infants with Congenital Diaphragmatic Hernia in Europe: The CDH EURO Consortium Consensus – 2015 Update. Neonatology. 2016;110:66–74.
3 Leeuwen L, Fitzgerald DA. Congenital diaphragmatic hernia. Journal of Paediatrics and Child Health. 2014:667–73.
4 Menon S, Trudgill S. Risk factors in the aetiology of hiatus hernia: A metaanalysis. Eur J Gastroenterol Hepatol. 2011;23:133–8.
5 Callaway JP, Vaezi MF. Hiatal and Paraesophageal hernias. Clinical Gastroenterology and Hepatology. 2018;16:810–3.
6 Pauwels A, Boecxstaens V, Andrews CN, Attwood SE, Berrisford R, Bisschops S, et al. How to select patients for antireflux surgery? The ICARUS guidelines (international consensus regarding preoperative examinations and clinical characteristics assessment to select adult patients for antireflux surgery). Gut. 2019;68:1928–41.
7 Kahrilas PJ, Shaheen NJ, Vaezi MF, Hiltz SW, Black E, Irvin M, et al. American Gastroenetrological Association Medical Position statement on the Management of Gastroösophageal Reflux disease. Gastroenterology. 2008;135:1383–91.
8 Freedberg DE, Yang YX. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association. Gastroenterology. 2017;152:706–15.
9 Asche KU, Kaindlstorfer A, Pointer R. Operative/Interventionelle Verfahren zur Refluxtherapie. Chirurg. 2017;88:188–95.
10 Spechler SJ, Hunter JG, Jones KM, Lee R, Smith BR, Mashimo M, et al. Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn. N Engl J Med. 2019;381:1513–23.
11 Garg S. Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease (GORD) in adults. Cochrane Database Syst Rev. 2015; (11):CD003243.
12 Seo HS, Choi M, Son SY, Kim MG, Han DS, Lee HH. Evidence-Based Practice Guideline for Surgical Treatment of Gastroesophageal Reflux Disease 2018. J Gastric Cancer. 2018;18:313–27.
13 Skubleny D, Switzer NJ, Dang J, Gill RS, Shi X, de Gara C, et al. LINX magnetic esophageal sphincter Augmentation versus Nissen fundoplication for gastroesophageal Reflux disease: a systemic review and metaanalysis. Surg Endosc. 2017;31:3078–84.
14 Singh S, Garg S, Singh P, Lyer P, El-Serag H. Acid-suppressive medications and risk of esophageal adenocarcinoma in patients with Barrett̍s esophagus: a systematic review and meta-analysis. Gut. 2014;63:1229–37.
15 Jankowski J, de Caestecker J, Love SB, Reilly G, Watson P, Sanders S, et al. Esomeprazole and aspirin in Barrett’s oesophagus (AspECT):a randomised factorial trial. Lancet. 2018;392:400–08.
16 Splittgerber M, Velanovich V. Barrett Esophagus. The Surgical clinics of North America. 2015;95:593–604.
17 El-Serag HB, Naik AD, Duan Z, Shakhatreh M, Helm A, Pathak A, et al. Surveillane endoscopy is associated with improved outcomes of oesophageal adenocarcinoma in patients with Barrett’s oesophagus. Gut. 2016;65:1252–60.
18 Stylopoulos N, Gazelle GS and Rattner DW. Paraesophageal Hernias: Operation or Observation? Ann Surg. 2002;236:492–500.
19 Sathasivam R, Bussa G, Viswanath Y, Obuobi RB, Gill T, Reddy A, et al. «Mesh hiatal hernioplasty» versus «suture cruroplasty» in laparoscopic paraoesophageal hernia surgery; a systematic review and meta-analysis. Asian Journal of surgery. 2019;42:53–60.
20 Abu Saleh WK, Morris LM, Tariq N, Kim MP, Chan EY, Meisenbach LM, et al. Routine use of mesh during hiatal closure is safe with no increase in adverse sequelae. Surg Endosc. 2018;32:879–88.
Références recommandées
– Pauwels A, Boecxstaens V, Andrews CN, Attwood SE, Berrisford R, Bisschops S, et al. How to select patients for antireflux surgery? The ICARUS guidelines (international consensus regarding preoperative examinations and clinical characteristics assessment to select adult patients for antireflux surgery). Gut. 2019;68:1928–41.
– Freedberg DE, Yang YX. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association. Gastroenterology. 2017;152:706–15.
– Garg S. Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease (GORD) in adults. Cochrane Database Syst Rev. 2015; (11):CD003243.
– Seo HS, Choi M, Son SY, Kim MG, Han DS, Lee HH. Evidence-Based Practice Guideline for Surgical Treatment of Gastroesophageal Reflux Disease 2018. J Gastric Cancer. 2018;18:313–27.
– Sathasivam R, Bussa G, Viswanath Y, Obuobi RB, Gill T, Reddy A, et al. «Mesh hiatal hernioplasty» versus «suture cruroplasty» in laparoscopic paraoesophageal hernia surgery; a systematic review and meta-analysis. Asian Journal of surgery. 2019;42:53–60.